1 Annual Report Division of Geriatric Medicine Department of
Transcription
1 Annual Report Division of Geriatric Medicine Department of
Annual Report Division of Geriatric Medicine Department of Medicine - Jewish General Hospital January 1 - December 31, 2013 SUMMARY We continue to fulfill the mandate of 1) delivering high-quality care to our elderly patients, 2) providing excellent teaching milieu to medical students and residents, 3) performing relevant clinical research on aging by our division members and 4) innovating in services to the elderly population. We are particular proud of the achievements in reducing waiting time to access our outpatient services and the success so far of the Elderly Friendly Hospital implementation program at the JGH. The Division of Geriatric Medicine continues to respond to the increasing demands for clinical services. The Division’s areas of clinical activities include the Geriatric’s Ward 6NW, the outpatient Geriatric Assessment Unit, Memory Clinic, Senior Oncology Clinic, the Geriatric Consultation Services in the Emergency Room, and in the hospital. To improve the efficiency of the Division’s many activities, we have assigned a physician coordinator for each of them. Thus for the 6NW Ward, the Medical Director will remain Dr. Ruby Friedman; for consultation services, Dr. Paul Heilpern; for out-patient clinics, Dr. Sanda Popescu; for Memory Clinic, Dr. Susan Vaitekunas and Dr. Howard Chertkow (Neurology). The Division continues to be jointly run by Dr. Ruby Friedman, JGH Site Director, and by Dr. José A. Morais, Director, McGill Division of Geriatric Medicine. 1. Research and publications: Research in neurobiology and dementia, health services, frailty, pharmacoepidemiology, long term care, and education continue to represent the existing strengths of the Division with programs that cross hospital, department and university lines and in some cases integrate bench-to-bedside-to population. Oncology and older persons, as well as empowering primary care to manage elderly patient with chronic diseases are emerging interests. There is increasing collaboration with colleagues from Quebec, Canada and internationally. Members of the Division lead major research programs with funding from the Canadian Institutes on Health Research (CIHR) and the Fonds de la recherche du Québec – Santé (FRQS). The list of publications and grants for our Divisions members are included in Section II. 2. Teaching and learning (undergraduate and graduate): Geriatrics is a mandatory rotation during the 4th year of medical clerkship and the JGH alone receives half of the medical students. This year, we had 2 residents in the Geriatric Fellowship program and 3 in the Care of the Elderly Program (Family Medicine stream) rotating at the JGH. We also have many Internal Medicine and Family Medicine residents spending a month rotating in the Division. The student evaluations have been very good to excellent and an increasing number of students have expressed interest in geriatric medicine as a career. Those of the Residents are also very positive. These positive evaluations are a testimony to the hard work and dedication of all the teachers in our Division. An annual Prize is given to a Medical Student with a superior performance in the rotation during the Graduation Day in May of each year 1 3. Involvement in the community: The McGill Division of Geriatrics held 7 Grand Rounds that are open to public as well as to physicians of all backgrounds and allied health professionals. Half of these conferences took place at the JGH. Some of our physicians act as consultants at Long Term Care Institutions and Rehabilitation Centers of the CSSS Cavendish and de la Montagne. 4. Partnerships: At the level of the JGH, we are working with the Departments of Nursing and Social Services in the implementation of the Approche adaptée à la personne âgée (AAPA). We are collaborating with the Department of Family Medicine, as part of the provincial Plan Alzheimer, to implement a memory clinic in their UMF/GMF. The Division works also in partnership with the Solidage Research Group (Dr. Johanne Monette, co-director) to innovate in the services and care to elderly patients. At the level of the RUIS McGill, several members of the Division participate in the Subcommittee of Aging and the Centre d’Excellence in Aging and Chronic Disease to assist in their orientations and to collaborate in projects. At the provincial level, we are also participating in the orientation of the MSSS-Table Nationale of Aging to improve the services and care to elderly patients and the Working group on the Implementation on the provincial Alzheimer Plan. 5. Milestones: A major development this year has been the introduction of the Approche adaptée à la personne âgée (AAPA). This is a hospital wide program to introduce principles of geriatric care on all units. The main focus of this program is on delirium diagnosis and management, mobility and nutrition Dr. Ruby Friedman is co-chair along with Judy Bianco (Director of Nursing for Medicine and Geriatrics), Sonia Joly (Nursing), and Maxine Lithwick (Director of Social Services). A large dedicated multidisciplinary team has played a leading role in the introduction of this Program. We have been recognized by the Agence de Montréal to be leaders in the implementation of this Program that could be the most advanced in its introduction onto the clinical wards of any hospital on the island of Montréal. The Geriatric Ward 6 NW is a fully renovated 32-bed unit which incorporates the principles of an “elderly friendly hospital”. The great concern in previous years was the increasing length of stay of patients on the Ward. This was mostly attributed to inefficiencies in the Program 68 placement process. This year we have seen a marked improvement in this process, now called PHPE for Programme d’Hébergement pour Évaluation. Consequently, since 2012, length of stay has decreased from 37.4 days to 28.1 days, and admissions have increased from 310 to 421. Dr. Friedman continues to work closely with nursing administration and the director of social service to ensure the functioning of this program. In response to the increasing request from the community, the hospital and the Emergency Room, the Outpatient Geriatric Clinics have markedly reduced waiting times for patient evaluation. The Outpatient Clinics include the Geriatric Assessment Unit, the Memory Clinic, and the Senior Oncology Clinic. The waiting period for new requests for consultation has been reduced to 2-4 weeks. Furthermore, the Rapid Response Clinic has been established whereby patients who require urgent follow-up from the Emergency Room, or are post-discharge, can be evaluated within days 2 (See Appendix 1 for stats). In the past year, the Geriatric consultation services in the Emergency Room and for the hospital Wards have been reorganized. For hospital ward consultations, 90% are completed within 48 hours. A similar percentage is achieved for ER consultations but within 24 hours. 6. New hires, promotions, and retirements There has been no change in the manpower. 7. Honours, awards, and prizes: Morais, J. - President of the Canadian Geriatrics Society (2013) -Betty Havens Award in longitudinal research (as one of the principal investigators of the NuAge Study; Canadian Gerontology Association) (2013) Schipper, Hyman -Hinman Prize for best poster presentation, McGill University, Faculty of Dentistry Student's Table Clinics Day, Feb.18, 2013. Salivary redox in benign lesions and breast cancer in women mellitus (D. Salah, A. M. Velly, L. Panasci, S. Gravel, A. Lisbona, H. M. Schipper, M.Gornitsky). -An 'HO-1 transducer' model of developmental and degenerative brain disorders (Tavitian A, Song W, Zukor H, Lin S-H, Hascalovici J, Liberman A, Mui J, Vali H, Tong X-K, Bhardwaj S, Srivastava L, Hamel E, Schipper HM). Highlighted by the American Academy of Neurology as a 'selected advance in neurologic diseases through basic science', 65th AAN Annual Meeting, San Diego, March 16-23, 2013. -Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment. Song W, Liberman A, Schipper HM. Selected for special recognition at the 3rd World Parkinson Congress, Montreal, October 1-4, 2013. Fundraising: N/A 8. SECTION I - DIVISION STATUS UPDATE 1. Mission and objectives of the Division The Mission of the Division is to provide comprehensive, compassionate, client-centered care to frail older persons and their caregivers to enhance their health and quality of life. Our objectives are: To provide exemplary geriatrics comprehensive assessment, consultation and direct care to our inpatient and outpatient elderly population to provide excellent education and training of students and residents to enhance their capacity to take care of future older persons 3 2. to provide leadership in ongoing research to advance knowledge of aging and aging related diseases and their management A nominative list of academic staff, their academic rank Dr. José Morais, Director, McGill Div. of Geriatric Medicine, Associate Professor, Active Dr. Ruby Friedman, Site Director, JGH, Div of Geriatric Medicine, Associate Professor, Active Dr. Sanda Popescu-Crainic, Active Dr. Howard Bergman, Professor, Active Dr. Johanne Monette, Assistant Professor, Active Dr. Gillian Fisher, Faculty Lecturer, Active Dr. Susan Gold, Assistant Professor, Active Dr. Paul Heilpern, Faculty Lecturer, Active Dr. Nacera Belkous, Faculty Lecturer, Active Dr. Susan Vaitekunas, Faculty Lecturer, Active Associate Members Dr. Yves Bacher, Active Dr. Catherine Brodeur, Active Dr. Howard Chertkow, Professor, Active Dr. Francine Gaba, Active Dr. Gary Inglis, Active Dr. Andréa Leblanc, Active Dr. Ziad Nasreddine, Active Dr. Hyman Schipper, Active Dr. Doreen Wan-Chow-Wah, Active SECTION II - GRANTS, PUBLICATIONS, AND SERVICE OUTSIDE OF McGILL 1. Grants and awards received Bergman, Howard -Canadian Longitudinal Study on Aging (CLSA)-Mobility Initiative (CMI) – An Emerging Team in Mobility in Aging. Raina P, Kirkland S, Wolfson C (PI’s). Bergman H et al (co-applicants). Canadian Institutes of Health Research. $1,487,100 ($247,850/year) (2008-2014) -Canadian Longitudinal Study on Aging. Raina P, Kirkland S, Wolfson C. Bergman H et al (coapplicants). Canadian Institutes of Health Research. $23,500 (2009-2014) -Le diagnostic et la prise en charge des patients avec troubles cognitifs en première ligne: Déterminer les modèles d'intervention les plus efficaces et leurs conditions de succès. Vedel I & Bouchard P (PI), Beland F, Bergman H, Bouchard M, Lapointe L, Monette J, Pelletier C, Pluye P. CIHR. $99,728 (2012-2013) -Measurement of Frailty to identify high-risk elderly patients referred for surgical and transcatheter aortic valve replacement. Afilalo J (PI), Bergman H, Morais J, Perrault L, Popma J, Cabau R, Shahian D. CIHR. $360,000 (2012-2016) -FRQS Projet de développement stratégique innovant - Optimisation de la valeur des soins aux patients par une organisation agile du système hospitalier. Institut Lady-Davis de l’HGJ : Beland F (PI). Bergman H (a co-investigator) in 2 themes: Quality of Care; Clinical and management decision processes: $1,400,000. ($350,000/year) (2012-2016) -« La prise en charge des personnes avec démence en première ligne : l’implantation et l’évaluation 4 d’un programme régional ». Vedel I (PI); Principal Knowledge User: P Bouchard; co-applicants: Bergman H, Beland F, et al. CIHR-Pfizer Operating Grant in Disease Prevention and Management. $197,480. (2012-2013) -“Processes of Cancer Treatment Decision Making Among Older Men and Women with Colorectal Cancer.” Strohschein FJ (PI), Loiselle CG, Bergman H, Schreiber RS, Botorff JL (co-applicants). Oncology Nursing Society Foundation Small Research Grant. $24,212 (2013-2015) -“Plan d’action ministériel sur les troubles cognitifs liés au vieillissement : une évaluation de l’implantation et des résultats des projets initiaux en vue d’une généralisation progressive au Québec”. Vedel I (PI), Couturier Y, Aubin M, Kaczorowski J, Bergman H, Haggerty J, Rodriguez C, Fortin M, Kroger E, Borgès Da Silva R (co-investigators). Fonds Pfizer-FRQS-MSSS. $500,000 (2013-2015) -PROMPT Identification of Cerebral Palsy: Primary-care Referral Of Motor-impaired children: Physician Tools. Majnemer A (PI), Fehlings D, Radzioch Guerin A, Ahmed S, Bergman H, Bussieres A, Dagenais L, et al (co-applicants). CIHR. Knowledge Translation Research Committee. $330,576. ($82,644/year) (2014-2018) Chertkow, Howard -CIHR (Canadian Institutes of Health Research) operating grant of $645,866: Joubert, S (P.I.), Bocti, C., Chertkow, H., Holcroft, C. The impact of beta-amyloid burden on cognition in normal aging. (2012-17) -CIHR (Canadian Institutes of Health Research) operating grant of $153,300/year: Chertkow, H. (P.I.), Soucy J., Thiel, A. Anomia in Alzheimer's Disease: Untangling semantic components and delivering therapy with rTMS. (2012-15) -CIHR (Canadian Institutes of Health Research) operating grant of $197,225.00/year: Bohbot, V (P.I.), Bherer, L., Chertkow, H., Gauthier, S., Lerch, J., Rajah, M. Virtual reality based spatial memory intervention for patients with Mild Cognitive Impairment. (2012-16) -Canadian Consortium on Neurodegeneration in Aging (CCNA) - $72,000.00. (2013) -Canadian Consortium on Neurodegeneration in Aging (CCNA) - $25,000.00. (2013) -CIHR (Canadian Institutes of Health Research) operating grant of $4,000,000/ 5 years: Rockwood, K. (P.I.) Chertkow, H. one of 4 co-investigators. “Canadian Dementia Knowledge Translation Network (CDKTN)” (2008-13) LeBlanc, Andréa -MOP 102738 CIHR operating grant –January 1, 2010 to March 31, 2015 Regulation of prion protein expression, trafficking, and function. Principal investigator: Andréa LeBlanc $689,580. -2011MOP-243413-BCA-CGAG-45097 CIHR (renewal of MOP 81146), operating grant, October 1, 2011- September 30, 2016, Role of caspases in human neuronal cell death and in Alzheimer's disease, Principal investigator: Andréa LeBlanc, $781,294 =$156,256 per year (Ranked 1st) -Research contract with Merck, Sharp, and Dhome on Caspase-6 inhibitors. July 2012-June 2013. $250, 000 operating funds and $100,000 overhead. -FRSQ-Pfizer Consortium Québecois de la Recherche sur la maladie Alzheimer au Québec (CIMAQ) Co-Principal Investigator: Andréa LeBlanc $2, 500, 000 April 2013-March 2016 Monette, Johanne -RADAR: A new screening tool to improve the recognition of delirium among older persons. Champoux N & Voyer P (PI), Desrosiers J, Hottin P, Landreville P, Mccusker J, Monette J, Savoie ML. CIHR. $424,631 (2010-2014) -Utilisation des services médicaux d’urgence et hospitaliers chez la clientèle agée de 75 ans et plus. 5 Quel est l’impact de l’accès aux ressources médicales et communautaires de première ligne. Afilalo M & Vedel I (PI), Grad R, Monette J. FRSQ. 260,213$ (2011-2014) -A systematic review of factors influencing older adults' decision to accept or refuse cancer treatment proposed by their physician. Alibhai M & Puts M (PI), Fitch M, Howell D, Krzyzanowska M, Leighl N, Monette J, Wan-Chow-Wah D. CIHR. $51,835 (2012-2013) -Implantation d’une intervention visant à optimiser la médication pour les patients atteints d’une démence avancée: un projet pilote. Edeltraut K & Wilchesky M (PI), Arcand M, Durand P, Aubin M, Voyer P, Monette J, Champoux N, Verreault R & Marcotte M. Total amount: 45,000$; (RQRV: 30,000 $, CEVQ 15,000$) (2013-2014) Morais, José A. -Research Institute/Hutchison Foundation. The impact of exercise training and leucine supplementation on skeletal muscle in frail elderly women with an exploration into mechanistic explanations. PI: Morais, JA. MUHC. $40,000 (2012-2014) -Planning Grant: Les maladies chroniques chez les Ainés: un portrait du domaine scientifique au Québec pour la planification stratégique du Centre d’Excellence sur le vieillissement et les maladies chroniques du RUIS McGill (Réseau Universitaire Intégré de Santé McGill). PI: Morais, JA. Coapplicants :Tanon A., Bouthilier F, Vedel I, Beland F. CIHR. $23,000. (2013-2014) -Provincial Network Funding Program to the Quebec Network for Research on Aging. (PI): Gaudreau P, Morais JA, Co-applicants: 15 researchers from various Quebec institutions. FRQS – RQRV. $900,000/yr (2012-2016) -Dairy Intakes of Older Adults of the NuAge Longitudinal Study: Impact on Body Weight and Composition, Physical and Cognitive Function and Metabolic Profile. PI: Chevalier S. Coapplicants: Morais JA, Payette H, Shatenstein B, Gaudreau P. Dairy Farmers of Canada. $109,600 (2013-2015) -Hypohydratation: Évaluation et comparaison de ses effets sur la force, la puissance et l’endurance musculaire chez des personnes jeunes et âgées. PI: Goulet E. Co-applicants : Morais JA. FRQSRQRV. $15,000. (2013-2014) -Measurement of Frailty to Identify High-Risk Elderly Patients Referred for Surgical and Transcatheter Aortic Valve Replacement. PI: Afilalo J. Co-investigators: Morais JA, Bergman H, Perrault L, Popma J, Rodes Cabau J, Shahian D. CIHR. $115,351/y. (2012-2016) -Mechanisms of insulin resistance of protein metabolism in human obesity. (PI): Marliss E. Coinvestigators: Morais JA, Gougeon R, Chevalier S. CIHR. $140,240/year (2003-2006), $157,452/year (2006-2009), $163,875/year (2009-2014) Schipper, Hyman -Canadian Institutes of Health Research (CIHR) ($753, 920 over 5 years). “Role of heme oxygenase-1 in aging and parkinsonian neural tissues (III)”. PI: Hyman Schipper -Mary Katz Claman Foundation ($85,000): 1) “Alzheimer research at the JGH Centre for Neurotranslational Research III” 2) “Establishment of an Alzheimer Risk Assessment Clinic (ARAC) at the JGH III” -Apopharma Inc. Effects of deferiprone on brain iron deposition and Parkinsonian features in GFAP.HMOX1 transgenic mice ($77,237). PI: Hyman Schipper 2. Scholarly works published in the 2013 calendar year: Publications 6 Bergman, Howard Puts M, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H. The fall rate of older community-dwelling cancer patients. Supportive Care in Cancer 2013 Mar; Vol 21(3):775-783. Vedel I, Ghadi V, De Stampa M, Routelous C, Bergman H, Ankri J, Lapointe L. Diffusion of a Collaborative Care Model in Primary Care: A Longitudinal Qualitative Study. BMC Family Practice 2013, 14:3 doi:10.1186/1471-2296-14-3 Khanassov V, Vedel I, Bergman H. Are non-attenders a concern for primary care practice? Israel Journal of Health Policy Research. 2013 Mar; 2:13 doi:10.1186/2045-4015-2-13 Sourial N, Bergman H, Karunananthan S, Wolfson C, Payette H, Gutierrez-Robledo LM, Béland F, Fletcher J, Guralnik J. Implementing frailty into clinical practice: a cautionary tale. Journal of Gerontology: Medical Sciences (Sourial and Bergman contributed equally to this article) 2013 May 2 doi:10.1093/gerona/glt053 Bergman H, Karunananthan S, Gutiérrez-Robledo LM, Brodsky J, Chan P, Cheung M, Bovet P. Understanding and Meeting the Needs of the Older Population: A Global Challenge. Canadian Geriatrics Journal. 2013 June; Vol 16 (2): 61-65, doi.org/10.5770/cgj.16.60 Williams J.B, Alexander K.P, Morin J-F, Langlois Y, Noiseux N, Perrault L. P, Smolderen K, Arnold S. V, Eisenberg M. J, Pilote L, Monette J, Bergman H, Smith P. K, Afilalo J. Preoperative Anxiety as a Predictor of Mortality and Major Morbidity in Patients >70 Years of Age Undergoing Cardiac Surgery. The American Journal of Cardiology. 2013 Jan 1;111(1):137-42. doi: 10.1016/j.amjcard.2012.08.060. De Stampa M, Vedel I, De Montgolfier S, Buyck J-F, Thorez D, Gazou F, Henrard J-C, Bergman H and Ankri J. Single entry point in a gerontological network for addressing the needs of older people. Santé Publique. 2013 Jan-Feb; 25(1):7-14. Puts MTE, Monette J, Girre V, Sourial N, Wolfson C, Monette M, Batist G and Bergman H. The relationship of self-rated health with functional status, toxicity and mortality: results of a prospective pilot study with older newly-diagnosed cancer patients. Journal of Geriatric Oncology 4 (2013); 319-326. doi:10.1016/j.jgo.2013.07.003 Berrut G, Andrieu S, Araujo de Carvalho I, Baeyens J.P., Bergman H, Cassim B, Cerreta F, Cesari M, Cha H.B., Chen L.K., Cherubini A, Chou M.Y., et al. Promoting access to innovation for frail old persons. IAGG/WHO/SFGG Workshop, Athens January 20-21, 2012. The Journal of Nutrition, Health & Aging. 2013;17(8):688-693 Vedel I, Akhlaghpour S, Vaghefi I, Bergman H, Lapointe L. Health information technologies in geriatrics and gerontology: a mixed systematic review. Journal of the American Medical Informatics Association. 2013 Nov 1; 20(6):1109-19. Doi: 10.1136/amiajnl-2013-001705 Chertkow, Howard Ducharme, S., Guiot, M.C., Nikelski, J., & Chertkow, H. (2013). Does a positive PiB scan in a demented patient equal Alzheimer’s disease? JAMA Neurology, doi:10.1001/jamaneurol.2013.420. 7 Chertkow, H., Feldman, H. , Jacova, C., & Massoud, F. (2013) Definitions of dementia and predementia states in Alzheimer Disease and Vascular Cognitive Impairment: Consensus from the Canadian Conference on Diagnosis of Dementia. Alzheimer’s Research and Therapy. http://alzres.com/content/5/S1/S2. 5(Suppl 1):S2. McLaughlin, P. M., Anderson, N. A., Rich, J. B., Chertkow, H., & Murtha, S. J. E. (2013) Visual selective attention in amnestic mild cognitive impairment. Journals of Gerontology Series B: Psychological Sciences and Social Sciences. doi: 10.1093/geronb/gbt077. LeBlanc, Andrea Ramcharitar, J, Veronica Afonso, Steffen Albrecht, David Bennett, Andrea C. LeBlanc. Caspase-6 activity predicts lower episodic memory ability in aged individuals. (2013) Neurobiol. Aging 34(7):1815-24 [Canadian Foundation of Innovation, CIHR IAP-102238, and MOP-243413-BCACGAG-45097] Marc-André Déry*, Julie Jodoin*, Josie Ursini-Siegel, Olga Aleynikova, Cristiano Ferrario, Saima Hassan, Mark Basik, and Andréa C. LeBlanc. (2013) Endoplasmic reticulum stress induces ATF6alpha- and XBP-1-mediated prion protein gene expression in breast cancer. Breast Cancer Research 15(2):R22, * co-first authors [MOP89376 and MOP102738] LeBlanc, AC. (2013) Caspase-6 as a novel early target in the treatment of Alzheimer disease. European Journal of Neuroscience Special Issue: The neurobiology of Aging and Alzheimer’s Disease: Walking down the same road? 37:2005-2018 (Article chosen for cover of issue). Misiewicz, M. Jodoin, J. Ruth, D., LeBlanc, A.C. (2013) Identification of a novel Endoplasmic Reticulum Stress Response Element regulated by XBP1. J Biol Chem 288:20378-91 [CIHR MOP89376 and MOP102738]. Jasmine Ramcharitar, Steffen Albrecht, Veronica Afonso, David Bennett, Andrea C. LeBlanc. (2013) Cerebrospinal fluid Tau∆Caspase-6 reflects brain levels and cognition in aging and Alzheimer Disease. Journal of Neuropathology and Experimental Neurology (JNEN) 72:824-832 [Canadian Foundation of Innovation, CIHR IAP-102238, and 2011 MOP-243413-BCA-CGAG45097]. Nelly Godefroy, Jasmine Ramcharitar, Steffen Albrecht, Cynthia Goodyer and Andréa C. LeBlanc. (2013) Caspase-6 expression and activation in fetal and adult human tissues PloS One. 8(11):e79313. doi: 10.1371/journal.pone.0079313 [MOP 15118/ MOP 81146-CIHR Csp6]. Andrea C. LeBlanc, Jasmine Ramcharitar, Veronica Afonso, Edith Hamel, David A. Bennett, Prateep Pakavathkumar, Steffen Albrecht. (2014) Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment in mice and men. Cell Death and Differentiation, [MOP 15118/ MOP 81146-CIHR Csp6] Advanced online pub.doi:10.1038/cdd.2013.194 Monette, Johanne Williams J.B, Alexander K.P, Morin J-F, Langlois Y, Noiseux N, Perrault L. P, Smolderen K, Arnold S. V, Eisenberg M. J, Pilote L, Monette J, Bergman H, Smith P. K, Afilalo J. Preoperative Anxiety as a Predictor of Mortality and Major Morbidity in Patients >70 Years of Age Undergoing 8 Cardiac Surgery. The American Journal of Cardiology. 2013 Jan 1;111(1):137-42. (doi: 10.1016/j.amjcard.2012.08.060). Puts M, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H. The fall rate of older community-dwelling cancer patients. Supportive Care in Cancer. 2013 Mar; Vol 21 (3):775-783. Cole M, McCusker J, Voyer P, Monette J, Champoux N, Ciampi A, Vu TTM, Belzile E. The course of subsyndromal delirium in older long-term care residents. Amercian Journal of Geriatric Psychiatry. 2013 Mar; Vol 21 (3):289-96 Voyer P, McCusker J, Cole M.G., Monette J, Champoux N, Ciampi A, Belzile E, Vu M, Richard S. Nursing documentation in long-term care settings : new empirical evidence demands changes be made. Clinical Nursing Research. 2013 Feb 20. [Epub ahead of print] McCusker J, Cole M.G., Voyer P, Vu M, Ciampi A, Monette J, Champoux N, Belzile E, Dyachenko A. Environmental factors predict the severity of delirium symptoms in long-term care residents with and without delirium. Journal of the American Geriatrics Society. 2013 Apr;61(4):502-11. doi: 10.1111/jgs.12164. Epub 2013 Mar 21. Cole M.G., McCusker J, Voyer P, Monette J, Champoux N, Ciampi A, Vu M, Dyachenko A, Belzile E. Symptoms of Delirium Predict Incident Delirium in Older Long-Term Care Residents. International Psychogeriatrics. 2013 Jun;25(6):887-94. doi: 10.1017/S1041610213000215. Epub 2013 Mar 1 Mandilaras V, Wan-Chow-Wah D, Monette J, Gaba F, Monette M, Alfonso L. The impact of cancer therapy on cognition in the elderly. Frontiers in Pharmacology of Anti-Cancer Drugs, 19 April 2013 | doi: 10.3389/fphar.2013.00048 Puts MTE, Monette J, Girre V, Sourial N, Wolfson C, Monette M, Batist G and Bergman H. The relationship of self-rated health with functional status, toxicity and mortality: results of a prospective pilot study with older newly-diagnosed cancer patients. Journal of Geriatric Oncology 4 (2013); 319-326. doi:10.1016/j.jgo.2013.07.003 Voyer P, McCusker J, Cole M, Monette J, Champoux N, Vu TTM, Ciampi A, Sanche S, Richard S and Deraad M. Feasibility and acceptability of a delirium prevention program for cognitively impaired long-term care residents: A participatory approach. Journal of the American Medical Directors Association. October 2, 2013; doi: 10.1016/j.jamda.2013.08.013 Puts MTE, Santos B, Hardt J, Monette J, Girre V, Atenafu E, Spingall E and Alibhai S. An update on a systematic review of the use of geriatric assessment for older adults in oncology. Annals of Oncology. November 2013; doi:10.1093/annonc/mdt386 Morais, José Trutschnigg B, Kilgour RD, Morais JA, Lucar, E, Hornby L and Vigano A. Metabolic, nutritional and inflammatory characteristics in elderly women with advanced cancer. J Geriatric Oncology 2013;4:183-189. Shatenstein B, Gauvin L, Keller H, Richard L, Gaudreau P, Giroux F, Gray-Donald K, Jabbour M, Morais JA and Payette H. Baseline determinants of global diet quality in older men and women 9 from the NuAge cohort. J Nutr Health Aging 2013;17:419-25. doi: 10.1007/s12603-012-0436-y Presse N, Belleville S, Gaudreau P, Greenwood CE, Kergoat MJ, Morais JA, Payette H, Shatenstein B, Ferland G. Vitamin K status and cognitive function in healthy older adults.Neurobiol Aging. 2013;S0197-4580(13)00244-3. doi:10.1016/j.neurobiolaging.2013.05.031 Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. J Support Care Cancer 2013; 21: 3261-3270. doi:10.1007/s00520-013-1894-4 Parrott MD, Shatenstein B, Ferland G, Payette H, Morais JA, Belleville S, Kergoat MJ, Gaudreau P, Greenwood C. Socioeconomic indicators restrict the cognitive impacts of diet patterns: the NuAge study. J Nutr.2013 Nov;143(11):1767-73. doi: 10.3945/jn.113.181115 Schipper, Hyman Garnier N, Petruccelli LA, Molina MF, Kourelis M, Kwan S, Diaz Z, Schipper HM, Gupta A, Del Rincon S, Mann KK, Miller WH.. The novel arsenical darinaparsin circumvents BRG1-dependant, HO-1-mediated cytoprotection in leukemic cells. Leukemia 1-9, 2013. doi: 10.1038/leu.2013.54 Alaoui-Jamali MA, Szarek WA, Nakatsu K, Vlahakis JZ, Gupta A, Bismar TA, Schipper HM. Preclinical anti-cancer studies of novel selective inhibitors of heme oxygenase signaling international Congress on Targeted Anticancer Therapies, Paris, March 4-6, 2013. *Tavitian A, *Song W, *Zukor H, *Lin S-H, *Hascalovici J, *Liberman A, Mui J, Vali H, Tong XK, Bhardwaj S, Srivastava L, Hamel E, Schipper HM. An 'HO-1 transducer' model of developmental and degenerative brain disorders, Neurology 80: S15.006, 2013. *Song W, *Tavitian A, *Zukor H, Lin S-H, *Hascalovici J, *Liberman A, Tong X-K, Bhardwaj SK, Srivastava LK, Hamel E, Schipper HM The GFAP.HMOX1 transgenic mouse model of schizophrenia: I. Behaviour and Neurochemistry. 7th Annual Canadian Neuroscience Meeting, Toronto, May 21-24, 2013; http://www.can-acn.org/meeting2013/documents/CANACN_Abstract_Booklet_Web.pdf; p.216. *Tavitian A, Song W, *Zukor H, *Lin S-H, *Hascalovici J, *Liberman A, Mui J, Vali H, Fillebeen C, Pantopoulos K, Wu T-D, Guerquin-Kern J-L, Schipper HM. The GFAP.HMOX1 transgenic mouse model of schizophrenia: II. Neuropathology. 7th Annual Canadian Neuroscience Meeting, Toronto, May 21-24, 2013; http://www.can-acn.org/meeting2013/documents/CANACN_Abstract_Booklet_Web.pdf; p.217. *Song W, *Liberman A, Schipper HM. Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment. 3rd World Parkinson Congress, Montreal, October 1-4, 2013. J Parkinsons Dis, Vol. 3, Suppl. 1, p. 69, 2013 Afilalo R, Schipper HM. The Kabbalistic Radla and quantum physics: analogies and differences. Torah u-Madda Journal 16: 134-152, 2012-13. *Trainees under Dr. Schipper's supervision 10 Abstracts published or presented Bergman, Howard -Bergman H, Vedel I, Moore A, Lee L, Tourigny A. A collaborative care model in primary health care for persons with Alzheimer’s disease/related disorders and with other chronic diseases. 20122013 Primary Health Care System (PHCS) Research Rounds. -Khanassov V, Vedel I, Pluye P, Bergman H. What Are the Barriers to Consistent Results in Case Management Targeting Patients With Cognitive Impairment in Primary Medical Care and Community Settings? A Systematic Mixed Studies Review. 40th NAPCRG 2012 Annual Meeting. New Orleans, Louisiana (December 1, 2012) -Puts M.T.E, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H. The relationship of self-rated health with measures of functional status and mortality: results of a prospective pilot study with older newly-diagnosed cancer patients. CGS 33rd Annual Scientific Meeting 2013. Toronto, ON (April 18-20, 2013) -Puts M.T.E, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H. The relationship of self-rated health with measures of functional status and mortality: results of a prospective pilot study with older newly-diagnosed cancer patients. MASCC/ISOO International Symposium on Supportive Care in Cancer 2013. Berlin, Germany (June 27-29, 2013). -Payette H, Bergman H, Wolfson C, Gaudreau P, Gray-Donald K, Morais JA, Shatenstein B, Béland F, Malo N, Sourial N. Frailty is associated with subsequent functional limitation, disability and mortality in a well-functioning community-living elderly population. British Society of Gerontology’s 42nd Annual Conference. Oxford, UK (September 11-13th, 2013). -Vedel I, Bergman H. « Conditions de succès et barrières à l’implantation de nouveaux modèles de soins cliniques et organisationnels en première ligne pour les patients souffrant de maladie d’Alzheimer au Québec. » 33èmes Journees Annuelles de la Société Française de Gériatrie et Gérontologie. Paris, France (October 8-10, 2013). Morais, JA -Liu XJ, Morais JA. Evaluating accessibility time to rehabilitation services for Geriatrics patients. 33rd Annual Scientific Meeting of the Canadian Geriatrics Society. Marriott Eaton Centre, Toronto. April 18-20, 2013. Can Geriatrics J Vol 16, p.72 June 2013. -Gouspillou G, Sgarioto N, Kapchinskty S, Purves-Smith F, Pion CH, Morais JA, AubertinLeheudre M, Hepple RT. Is mitochondrial function impaired with aging in human skeletal muscle? First Montreal International Symposium of Grapa. UQAM, Montreal May 3-4, 2013. J Frailty Aging 2013;2 :p.94*. -Morais JA. When sarcopenia meets frailty. First Montreal International Symposium of Grapa. UQAM, Montreal May 3-4, 2013. J Frailty Aging 2013;2 :p.98*. -Matta J, Mayo N, Dionne J, Payette H, Gaudreau P, Fulop T, Tessier D, Gray-Donald K, Shatenstein B, Morais JA. Comparisons of two indices of muscle mass index and their associations with the HOMA-IR score. First Montreal International Symposium of Grapa. UQAM, Montreal May 3-4, 2013. J Frailty Aging 2013;2 :p.106 -Barbat-Artigas S, Pion CH, Gouspillou G, Belanger M, Hepple RT, Morais JA, Aubertin-Leheudre M. Loss of muscle mass with aging without loss of muscle quality. First Montreal International Symposium of Grapa. UQAM, Montreal May 3-4, 2013. J Frailty Aging 2013;2 :p.106 -Pion CH, Barbat-Artigas S, Lemieux F, Hepple RT, Morais JA, Belanger M, Aubertin-Leheudre M. Distribution and quantity of thigh muscle and fat masses in young and older active men. First Montreal International Symposium of Grapa. UQAM, Montreal May 3-4, 2013. J Frailty Aging 11 2013;2 :p.106 -Gaudreau P, Fulop T, Payette H, Morais JA, Beland F. Blood biomarkers signature of frailty in the NuAge Cohort. IAGG Conference. Seoul. June 23-27 2013. 20th Annual Scientific Meeting of IAGG. Seoul, June 23-27, 2013.J Nutr Health Aging Vol 17, Suppl 1, 2013; p. S68 -Morais JA, Crisante R, Larente N. A Strategy to Create an Age-friendly Hospital: The McGill University Health Centre(MUHC) Experience. 20th Annual Scientific Meeting of IAGG. Seoul, June 23-27, 2013.J Nutr Health Aging Vol 17, Suppl 1, 2013; p. S220 -Morais JA, Matta J, Fulop T, Dionne IJ, Gaudreau P. 20th Annual Scientific Meeting of IAGG. Seoul, June 23-27, 2013. JNutr Health Aging Vol 17, Suppl 1, 2013; p. S201 -Matta J, Mayo N, DionneIJ, Payette H, Gaudreau P, Fulop T, Tessier D, Gray-Donald K, Shatenstein B, MoraisJA.Body composition and sex contribute to insulin resistance in the NuAge cohort of elderly people. J Nutr Health Aging Vol 17, Suppl 1, 2013; p. S355 -Gaudreau P, Fulop T, Morais JA. Blood biomarker profile of insulin resistance in the NuAge cohort.20th Annual Scientific Meeting of IAGG. Seoul, June 23-27, 2013. JNutr Health Aging Vol 17, Suppl 1, 2013; p. S202 -Kilgour R, Morais JA, Fulop T, Khalil A, Dionne IJ, Tessier D, Trutschnigg B, Vigano A. Low physical performance is associated with energy inefficiency and perceived fatigue in frail elderly women" has been accepted for a poster presentation. CSEP/SCPE 2013 Extreme Human Physiology: Pathology to Performance. Hyatt Regency, Toronto, Ontario. October 16-19, 2013 Applied Physiology, Nutrition, and Metabolism. Sept Suppl 2013 -Coussa A, Marliss EB, Morais JA, Chevalier S, Lamarche M, Tsoukas m, Gougeon R. Metabolic and Body Composition Responses to a Moderate Energy Restriction, Abundant Protein Diet in Type 2 Diabetic Adults. 16thCDA/CSEM Professional Conference and Annual Meetings Montreal, October 17-20, 2013. Canadian J Diabetes September suppl. 2013 -Burgos S, Chevalier S, Morais JA, Lamarche M, Marliss EB. Insulin Stimulates Grb10 Phosphorylation by mTORC1 and Mediates its Feedback Inhibition on P13K/Akt Signaling in Human Skeletal Muscle. 16thCDA/CSEM Professional Conference and Annual Meetings Montreal, October 17-20, 2013. Canadian J Diabetes September suppl. 2013. -Gougeon L, Gray-Donald K, Morais JA, Payette H. Dietary patterns are not associated with a 3year incidence of depression among healthy elderly Quebecers. The NuAge Study. Canadian Nutrition Society Annual Conference. Loews Hôtel Le Concorde, Quebec City May 30-June 2, 2013. Applied PhysiolNutrMetabol June Suppl 2013 Reports Bergman, Howard Bergman H, Grignon M, Cooper B, Bornstein S, Navarro P and O’Brien S. Community-Based Service Models for Seniors in Newfoundland & Labrador. Newfoundland & Labrador Centre for Applied Health Research, Newfoundland & Labrador (Oct 2013). ISBN: 978-0-88901-452-7 3. Academic and community engagement service outside of McGill by individual members of the unit Conferences Bergman, Howard -La Integracion de los componentes biologicos, clinicos y epidemiologicos del Sindrome de Fragilidad. Simposio: Internacional de Fragilidad. 2o Congreso Anual de la Sociedad de Geriatras de Mexico. Mexico City, Mexico (August 22, 2013) 12 -(Invited Honorary President) Innovations et actualités en onco-gériatrie. Symposium. 9èmes journées nationales EPO-G (Échange de Pratiques en Onco-Gériatrie). Paris, France (Sept 18-20, 2013) -Les soins de santé personnalisés : quels impacts sur le système de santé? Forum Santé International FSI-2013. Montreal, QC (22 Octobre 2013). -Vieillissement et défis du système de santé et des services sociaux: La responsabilité clinique à travers le parcours de soins. Forum Santé International FSI-2013. Montreal, QC (23 Octobre 2013). -Developing and Implementing Provincial Alzheimer Strategies: Lessons learned from the Quebec Alzheimer Plan. 7th CCD Canadian Conference on Dementia. Vancouver, BC (Oct 3-4-5, 2013) -The Quebec Alzheimer Plan: The Never-Ending Cycle from Practice to Research to Policy and Back. Participatory Research at McGill (PRAM). McGill - Department of Family Medicine. Montreal, QC (January 14, 2013) -Le Futur de la Médecine Familiale: Un nouveau modèle pour de meilleurs résultats. The 4th Annual Science & Policy Exchange. Montreal, QC (September 27, 2013) Chertkow, Howard -Distinguishing amyloid positive from amyloid negative Mild Cognitive Impairment patients Canadian Neurological Sciences Federation. Montreal: June 14, 2013. -Amyloid Positive MCI: Predicting progression to dementia. Alzheimer’s Association International Conference 2013. Boston: July 13-18, 2013. -Imaging modalities in Alzheimer’s disease – do results converge? Translational Imaging in Alzheimer's and Parkinson's Diseases. Montreal: Sept.30, 2013. -CCNA- a new strategy to bring together Canadian research on dementia. Journées de Recherche 2013 du RQRV. Quebec City: October 2, 2013. -What the Alzheimer Disease Neuroimaging Initiative (ADNI) Has Taught us: New Models, Game Changes and Enigmas. With Sandra Black. 7th Canadian Conference on Dementia. Vancouver: Oct. 4, 2013. -The New Canadian Consensus Conference Guidelines on Dementia. Workshop at 7th Canadian Conference on Dementia. Vancouver: Oct. 5, 2013. -Alzheimer’s Disease – at the Jewish General, McGill, Canada, and the World. Shedding a New Light on Alzheimer’s Research - Weitzmann Canada. Montreal: October 8, 2013. Media Presentations and Coverage: -The Nature of Things hosted by David Suzuki, Featured in episode “Untangling Alzheimer’s”, November 14, 2013. LeBlanc, Andrea -The role of Caspase-6 in Alzheimer Disease. Université de Montreal. Hôpital Notre-Dame. February 21, 2013 -Cdk5 phosphorylation of human PrP mutants increases PrP conversion. Chosen from abstract for short talk. Protein misfolding in Disease. Roscoff, France April 13-17, 2013 -Caspase-6 activation in the non-cognitively impaired aged and in Alzheimer's disease. Religious Order Study (ROS)/MAP investigator meeting. Chicago, IL May 29 & 30, 2013. -Nouvelles pistes moléculaires de la maladie Alzheimer et maladies à prions. Département de Biochimie, Université Sherbrooke, Quebec, November 4, 2013 Morais, JA -First Montreal International Symposium of Grapa: Muscle – from Humans to Cells. When 13 sarcopenia meets frailty. UQAM, Pavilion of Science, Montreal. May 4, 2013 -International Association of Geriatrics and Gerontology 2013. Canadian Geriatrics Society Symposium: Initiatives to improve the acre of Hospitalized Elderly Persons. A strategy to create an Age-friendly Hospital: The McGill Health Care Centre Experience. Seoul, Korea. June 26, 2013. -International Association of Geriatrics and Gerontology 2013. Symposium on Relating muscle mass with functional capacity and insulin resistance: what is apparent is not always real. Body composition changes and its relationship with the development of insulin resistance in participants of the NuAge cohort. Seoul, Korea. June 25, 2013 -First Annual World Congress of Geriatrics and Gerontology 2013. Symposium on Protein Metabolism and Homeostasis in Aging.Optimal Protein Intakes and Metabolism for Preservation of Muscle Mass with Aging. Dalian, China. October 12 , 2013 -Second France-Québec conference in dementia: « Vieillissement et démences, un double défi ». La prévention de la démence doit débuter bien avant l'âge d'or: une révision des facteurs de risques. Académie Nationale de Médecine, Paris, France. October 21, 2013 -26è Congrès de la Société québécoise de gériatrie. Comprendre la sarcopénie pour mieux cerner la fragilité. LowesHotel Le Concorde, Québec City, Novembre 15, 2013 -66th Annual Scientific Meeting Gerontological Society of America.Symposium: Nutrition as a Determinant of Successful Aging: Results from the NuAge Study Contributors to insulin resistance in the NuAge cohort. Sheraton and Marriott Hotels, New Orleans, November 23, 2013. -Congrès annuel de l’Ordre professionnel des diététistes du Québec. Personne âgée et gériatrie : adapter l’approche nutritionnelle au diabète et à la sarcopénie. Pathophysiologie et approche médicale du diabète chez la personne âgée. CHU Sainte-Justine, Montreal. February 14, 2013 -Conferences of the Groupe de recherche en activité physique adaptée (Grapa). Anabolique responses to a simulatedmeal in elderlypersons. Université du Québec à Montréal, Complexe des Sciences, Pavillon SB. April 9, 2013 -Regional Geriatric Rounds of the Of the Eastern Ontario. Understanding the link between sarcopenia and frailty. The Ottawa Hospital Civic Campus. September 20, 2013 -First International Conference of Geriatrics. Nutrition and exercise as modulators of frailty. King Fahad Medical City, Riyadh, Saudi Arabia, November 10, 2013 -First International Conference of Geriatrics. An Elderly-Friendly Hospital for the growing older inpatient population. King Fahad Medical City, Riyadh, Saudi Arabia, November 11, 2013 -First International Conference of Geriatrics. Approach to dementia, diagnosis and care. King Fahad Medical City, Riyadh, Saudi Arabia, November 11, 2013 -First International Conference of Geriatrics. Relevant aspects of nutrition in the elderly. King Fahad Medical City, Riyadh, Saudi Arabia, November 12, 2013 -Department of Exercise Science Lectures. Protein requirements and metabolism with aging. Loyola Campus, Concordia University. November 29, 2013. Schipper, Hyman -Can Alzheimer disease be prevented? Alzheimer Groupe Inc., Montreal, January 24, 2013. -Salivary redox in benign lesions and breast cancer in women mellitus (D. Salah, A. M. Velly, L. Panasci, S. Gravel, A. Lisbona, H. M. Schipper, M.Gornitsky). 49th Annual Dental Students’ Conference on Research, ADA Foundation, Gaithersburg, Maryland April 21-23, 2013. -Suppression of glial HO-1 hyperactivity as a novel therapeutic intervention in neurodegenerative diseases. Johnson & Johnson, Montreal, June 3, 2013. -Suppression of glial HO-1 as a novel therapeutic intervention in neurodegenerative diseases. NeoMed, Montreal, June 7, 2013. 14 Committee Work Bergman, Howard -Chair, Scientific Advisory Committee, CPHR and innovation Network (2013) -Co-honorary President, Société francophone d’oncogériatrie (2010-present) -Chair, Board of Directors, AllerGen NCE Inc. (2012-) -Chair, Program Awards Review Panel, Ontario Ministry of Health and Long-Term Care HSRF (2012-) -Chair, Scientific Advisory Committee, CPHR and innovation Network (2013-) Chertkow, Howard -Member, NIH Committee to review the Alzheimer’s Disease Cooperative Study (ADCS) Bethesda, Maryland, July 2012 -Executive member (elected), ISTAART (Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) , a professional society for individuals interested in Alzheimer's and dementia science ) 2012 -GE Amyloid Imaging Advisory Board. 2012 -Member, International committee to review the Ontario Brain Institute. 2012 LeBlanc, Andréa -Founder and co-coordinator with Dr Nicole Leclerc from U. de Montreal of a group of basic scientists working to understand the fundamental causes of Alzheimer disease. 2007-Chair of FRSQ chercheur boursier senior committee. 2010-2013 -Member of Biomedical Peer Review Panel of the Alzheimer Society Research Program (ASRP) -Membre du Comité d’orientation du Réseau Québecois de la Recherche sur le Vieillissement. 2012-2013 -Co-Directrice de l’Axe de Cognition, Réseau Québecois de la Recherche sur le Vieillissement 2013-2016 -Co-Directrice CIMA-Q (Consortium pour l’identification précoce de la maladie Alzheimer au Québec. 2013-2016 -Theme leader for CIMA-Q (Consortium pour l’identification précoce de la maladie Alzheimer au Québec) Molecular mechanisms of disease and Biomarkers section.2013-2016 Editorial Advisory Board member, Current Alzheimer Research, Bentham Science Publishers. June 2003-Editorial Board Member, The American Journal of Pathology, April 1 2004- present Academic Editor, PLoS ONE 2011Morais, JA -Director of the Division of Geriatrics (Executive Committee, Undergraduate Committee, Education Training Committee) 2009-Present -Member of the Executive Committee of the Canadian Geriatrics Society. (Vice-President 2011) Eight periods of 1 hours/year. 2008-Present -Member of the Steering Committee of the Regroupement des Unités de courte durée gériatriques et des services hospitaliers de gériatrie du Québec (RUSGQ). Six Periods of 2 hours. 2011-Present -McGill RUIS Sub committee of Aging – 3 periods of 2h. 2011-Present -Member of the Table NationaleVieillissement – Ministry of Health. Four periods of 3 hours. 2011 present -Associate Director of the Reseau québécois de recherche sur le vieillissement – FRQS. Monthly 15 meetings. 2010-Present -CIHR member of the Biological and Clinical Aspects of Aging Committee. May 30-31, 2013 -Director of Centre of Excellence in Aging and Chronic Disease of the RUIS McGill. Monthly 1 hour meetings. 2012 – present -Member of the McGill SPOR Committee. Monthly 1 hour meetings 2012 - 2013 -Member of the scientific Committee of the First Montreal International Symposium of Grapa: Muscle – from Humans to Cells. 2013 -CIHR member of the Biological and Clinical Aspects of Aging Committee. May 30-31, 2013 -American Journal of Physiology: Endocrinology and Metabolism -American Journal of Clinical Nutrition -Journal of the American Geriatrics Society -Journal of Nutrition Health and Aging -Member of the Editorial Board of the Canadian Journal of Geriatrics -Member of the Scientific Committee of the Annales de Gérontologie Schipper, Hyman -Chair, Canadian Institutes of Health Research (CIHR): Biological and Clinical Aspects of Aging (BCA) Grants Committee -Chair, LDI Internal Grant Review Committee SECTION III - CONFIDENTIAL INFORMATION 1. Consulting activities: Name of Faculty Member Private Sector Consulting (# of days) Howard Bergman Howard Chertkow Bristol Myers squibb (MCI trial) 10 Hyman Schipper Apopharma Inc. 10 José A. Morais Public Sector Other (# of days Total Consulting – please explain) (# days) MSSS implementation of 10 the QC AD Plan) 10 10 MSSS (implementation of the QC AD Plan) 10 10 10 Submitted by: Ruby Friedman, MD Site Director, Division of Geriatric Medicine José A. Morais, MD Director, McGill Division of Geriatric Medicine 16